I'm curious about something and don't recall ever seeing anything specific on this: What is the percentage now of CML patients at, say, 10 years of TKI therapy who have NOT reached beyond MMR? I don't know if it's just me, but I feel like so many people on this forum have reached PCRU or at least MR4 or 4.5, and at pretty early dates, too. The stop studies, of course, only include that cohort. I wonder about the rest of the general CML population. Is it somewhere around 75%? After the flurry over TFR settles down in the next few years, I sure hope someone looks out for the rest of us. If we haven't gotten below MMR in 10 years, is it ever going to happen?
#1
Posted 05 August 2016 - 10:33 AM
Dx July 2009 on routine physical. WBC 94. Started Gleevec 400 mg Sept 2009. MMR at 2yrs. Side effects (malaise, depression/anxiety, fatigue, nausea, periorbital edema) never improved. Kidney issues developed because of Gleevec. Switched to Sprycel 70 mg in Aug 2011. Above side effects disappeared or improved. Have been MR3.5 - 4.5 ever since. Two untreated pleural effusions followed by one treated by stopping Sprycel Jan 2017. After 9 weeks, PCR showed loss of MMR; re-started Sprycel at 50 mg and in 3 months was back to <0.01% IS. Pleural effusion returned within a couple of months, same as before (moderate, left side only). Stopped Sprycel 50 mg for 12 weeks; pleural effusion resolved. At about a monthoff the drug, PCR was 0.03; at 11 weeks it was 2.06 - lost CCyR? Have returned to 50 mg Sprycel for 3 weeks, intending to reduce to 20 mg going forward.
#2
Posted 05 August 2016 - 10:46 AM
Immunotherapy and what is going on in the UK is the real solution to our disease, not TFR. I'm still not 100% sold on that being a cure. Our bodies failed in that our immune systems did not detect and fix/destroy the LSC's, I don't believe that our immune systems (for those that are TFR) suddenly corrected themselves and there is no longer a problem. Scientists believe that LSC's can survive for decades so just because you are TFR today, doesn't mean that the CML won't be back tomorrow. Correcting our immune systems should always be the ultimate goal.
Yes, not having to take this damn medicine would be nice, but 50% of us, even when we reach PCRU, will still have to take the medicine. TFR is a nice to have but it isn't the cure.
08/2015 Initial PCR: 66.392%
12/2015 PCR: 1.573%
03/2016 PCR: 0.153%
06/2016 PCR: 0.070%
09/2016 PCR: 0.052%
12/2016 PCR: 0.036%
03/2017 PCR: 0.029%
06/2017 PCR: 0.028%
09/2017 PCR: 0.025%
12/2017 PCR: 0.018%
Taking Imatinib 400 mg
#3
Posted 05 August 2016 - 11:07 AM
I wonder if insurance companies won't eventually start to encourage and/or force people who are PCRU for a period of time to try stopping. They have a huge fiscal incentive to do this and as more studies say it is safe to try, I wonder if that will happen.
DX 3/30/2016 WBC 484.2 FISH 95.3
took Hydrea 3/30-4/11
taking Sprycel 100 mg since 4/5
10 day break from Sprycel for platelet count of 12 4/26-5/8
7/07/2016 1.47% (IS)
9/30/16 BMB PCR .1259 switched to new onc
12/30/16 PCR .1569
4/7/17 PCR .0904 MMR
7/14/17 PCR .0520
12/1/17 PCR .0148
#4
Posted 05 August 2016 - 11:24 AM
But does anyone know the percentage of people who have not gotten below MMR by 10 years?
Dx July 2009 on routine physical. WBC 94. Started Gleevec 400 mg Sept 2009. MMR at 2yrs. Side effects (malaise, depression/anxiety, fatigue, nausea, periorbital edema) never improved. Kidney issues developed because of Gleevec. Switched to Sprycel 70 mg in Aug 2011. Above side effects disappeared or improved. Have been MR3.5 - 4.5 ever since. Two untreated pleural effusions followed by one treated by stopping Sprycel Jan 2017. After 9 weeks, PCR showed loss of MMR; re-started Sprycel at 50 mg and in 3 months was back to <0.01% IS. Pleural effusion returned within a couple of months, same as before (moderate, left side only). Stopped Sprycel 50 mg for 12 weeks; pleural effusion resolved. At about a monthoff the drug, PCR was 0.03; at 11 weeks it was 2.06 - lost CCyR? Have returned to 50 mg Sprycel for 3 weeks, intending to reduce to 20 mg going forward.
#5
Posted 05 August 2016 - 01:05 PM
No reliable data on CMR (PCRU) but there is good data on patients continuing to achieve first-time MMR over 8 years:
http://www.ncbi.nlm....d-6-1-e2014007/
http://www.bloodjour...ent/116/19/3758
The IRIS study was the longest follow-up of any TKI group (8 years). If you look up data on IRIS you can find some useful data.
Extrapolating from the IRIS study info about MMR achievement continuing over many years, I am sure the same has happened for CMR, maybe even over a longer period of time.
#6
Posted 05 August 2016 - 01:33 PM
Insurance companies will probably put pressure on Oncologists rather than patients, they wouldn't want to risk a lawsuit.
08/2015 Initial PCR: 66.392%
12/2015 PCR: 1.573%
03/2016 PCR: 0.153%
06/2016 PCR: 0.070%
09/2016 PCR: 0.052%
12/2016 PCR: 0.036%
03/2017 PCR: 0.029%
06/2017 PCR: 0.028%
09/2017 PCR: 0.025%
12/2017 PCR: 0.018%
Taking Imatinib 400 mg
#7
Posted 05 August 2016 - 07:20 PM
08/17/2015- 14.793 % I.S P210 (quest)
10/15/2015- 3.313 % I.S (quest)
12/23/2015- 1.891 % I.S (quest)
1/07/2016- Tasigna 300mg 2x daily
1/14/2016- 4.414 % I.S P210- City Of Hope lab, mutation negative.
1/26/2016- 1.589 % I.S (quest)
2/22/2016- 1.719 % I.S (quest)
2/29/2016- 1.133 % I.S (quest)
3/03/2016- Tasigna 400mg 2x daily.
3/29/2016- 0.663 % I.S (quest)
4/27/2016- 0.781 % I.S (quest)
5/04/2016- 0.652 % I.S.(quest)
5/24/2016- 0.501 % I.S (quest)
6/28/2016-0.534 % I.S (quest)
7/15/2016-0.881 % I.S (quest)
7/22/2016- Bosulif 500mg
7/28/2016- t315i test- Negative
8/22/2016-0.432 % I.S (quest )
11/15/2016-0.325 % I.S (quest)
2/1/2017- .0445% i.s (genoptix)
5/6/2017- .0968% i.s (genoptix)
5/12/2017- .12 % i.s (quest).
6/4/2017- .083% i.s (quest)
6/11/2017- .0295% i.s (genoptix)
8/5/2017- .0501% i.s (genoptix)
11/6/2017- .0270% i.s (genoptix)
1 user(s) are reading this topic
0 members, 1 guests, 0 anonymous users